EMBL and Institut Pasteur forge an unprecedented European alliance to revolutionize infection biology research and develop new weapons against antimicrobial resistance.
The Institut Pasteur has partnered with the European Molecular Biology Laboratory (EMBL), Europe’s leading life sciences research organization, to advance interdisciplinary research in infection biology across Europe. Signed under a Memorandum of Understanding, this strategic collaboration leverages the Institut Pasteur’s world-renowned expertise in infectious diseases and immunology alongside EMBL’s cutting-edge capabilities in computational biology, structural biology, and advanced organoid systems.
Initiative “Amplifying Funds in Infection Biology”
The Institut Pasteur has already committed more than €1 million to the Institut Pasteur-EMBL initiative – underscoring its role as a foundational pillar in advancing infectious disease research in Europe. As a cornerstone of the Institut Pasteur’s long-term vision and strategy, “Pasteur 2030”, this partnership not only prioritizes transformative research addressing emerging infectious diseases, but also fosters a culture of scientific cooperation and cross-border collaboration. The program is committed to cultivating the next generation of scientific leaders by expanding international training opportunities, equipping young scientists with access to state-of- the-art technologies and mentorship from leading experts across Europe.
We aim to deepen this cooperation in the coming years, securing sustained support to amplify our joint research projects and strengthen training exchanges– ensuring a strong pipeline of future experts in infectious diseases and high impact research in infectious diseases.
As part of its broader commitment to scientific innovation, the Institut Pasteur is also investing in a landmark new facility – the Center for Vector-Borne Diseases (CMTV) – to deepen the understanding of infectious threats through advanced technological approaches. The EMBL-Institut Pasteur partnership plays a vital role in attracting top-tier scientific expertise to the CMTV and reinforcing the Institut Pasteur’s position as a leader in global health research.
